Suretrac
Payments companies reported to CMS as associated with Suretrac. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Suretrac, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Suretrac
These are the largest totals companies reported as associated with Suretrac. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Kenneth Binmoeller | San Francisco, CA | Gastroenterology (Internal Medicine) | $127.50 |
| Samuel Kim | New York, NY | Cardiovascular Disease | $18.13 |
| Saowanee Ngamruengphong | Baltimore, MD | Gastroenterology (Internal Medicine) | $18.13 |
| Tanuj Chokshi | Brick, NJ | Gastroenterology (Internal Medicine) | $13.94 |
| Amit Kashyap | Baltimore, MD | Gastroenterology (Internal Medicine) | $13.94 |
| Yasutoshi Shiratori | Brooklyn, NY | Gastroenterology (Internal Medicine) | $13.94 |
| Aaron Tokayer | Bronx, NY | Gastroenterology (Internal Medicine) | $13.94 |
| Manol Jovani | Miami, FL | Gastroenterology (Internal Medicine) | $13.94 |
| Seth Lapin | Brooklyn, NY | Internal Medicine | $13.94 |
| Negar Niknam | Tampa, FL | Gastroenterology (Internal Medicine) | $13.94 |
Prescribed Suretrac?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.